NewAmsterdam Pharma Co N.V.
NewAmsterdam Pharma Co N.V. (NAMS) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 62 transactions totaling $21.7M, demonstrating a bearish sentiment with -$20.7M in net insider flow. The most recent transaction on Jan 28, 2026 involved a transaction of 32,612 shares valued at $0.
NAMS Insider Activity Summary
Who Is Buying NAMS Stock?
No significant insider buying has been recorded for NAMS in the recent period.
Who Is Selling NAMS Stock?
No significant insider selling has been recorded for NAMS in the recent period.
Is NewAmsterdam Pharma Co N.V. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for NAMS is bearish with an Insider Alignment Score of 2/100 and a net flow of -$20.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
NAMS Frequently Asked Questions
Understanding NAMS Insider Activity
Insider trading at NewAmsterdam Pharma Co N.V. (NAMS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading NAMS stock, having executed 62 transactions in the past 90 days. The most active insider is Louise Frederika Kooij (Chief Accounting Officer), who has made 22 transactions totaling $15.9M.
Related Tools
Track NewAmsterdam Pharma Co N.V. Insider Activity
Get notified when executives and directors at NAMS file new Form 4 transactions